ArticleFrontiers in endocrinology2026
Peripheral blood inflammatory indices across thyroid functional states in Graves' disease: associations with liver biochemical abnormalities and hyperthyroid relapse.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Graves' disease is an organ-specific autoimmune disorder driven by thyrotropin receptor antibody (TRAb) and accompanied by persistent immune and inflammatory activation. Peripheral blood inflammatory indices are readily available and have been increasingly used to assess inflammation in autoimmune diseases. However, their clinical significance in Graves' disease across different thyroid functional states is unknown. Methods: In this retrospective study, 687 patients with Graves' disease were enrolled. Five peripheral blood inflammatory indices were calculated, including the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV). Patients were stratified and compared according to thyroid functional status. Because sex distribution differed among the groups, sex-adjusted median regression models were additionally fitted, and group-by-sex interactions were examined. Correlation analysis, logistic regression, and receiver operating characteristic (ROC) curve analysis were used to evaluate associations of these indices with clinical characteristics, liver biochemical abnormalities, and hyperthyroid relapse. The outcome models were internally validated using bootstrap resampling and repeated 10-fold cross-validation. Results: Sex distribution differed significantly among the thyroid functional groups. After adjustment for sex, MLR, SIRI, and PIV remained significantly higher in the overt hyperthyroid group than in the subclinical hyperthyroid and euthyroid groups. In patients with overt hyperthyroidism, MLR was positively correlated with age, FT3, FT4, ALT, and AST (r Conclusion: Compared with NLR and SII, the monocyte-containing indices MLR, SIRI, and PIV showed clearer differences across thyroid functional states in Graves' disease and may provide complementary inflammation-related information. Among them, MLR was associated with liver biochemical abnormalities, whereas PIV showed potential adjunctive value for hyperthyroid relapse risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.